Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2017 1
2018 1
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Potential peptides in atherosclerosis therapy.
Marleau S, Mellal K, Huynh DN, Ong H. Marleau S, et al. Among authors: mellal k. Front Horm Res. 2014;43:93-106. doi: 10.1159/000360568. Epub 2014 Jun 10. Front Horm Res. 2014. PMID: 24943301 Review.
Immunometabolic modulation of retinal inflammation by CD36 ligand.
Mellal K, Omri S, Mulumba M, Tahiri H, Fortin C, Dorion MF, Pham H, Garcia Ramos Y, Zhang J, Pundir S, Joyal JS, Bouchard JF, Sennlaub F, Febbraio M, Hardy P, Gravel SP, Marleau S, Lubell WD, Chemtob S, Ong H. Mellal K, et al. Sci Rep. 2019 Sep 9;9(1):12903. doi: 10.1038/s41598-019-49472-8. Sci Rep. 2019. PMID: 31501473 Free PMC article.
Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient mice.
Frégeau G, Sarduy R, Elimam H, Esposito CL, Mellal K, Ménard L, Leitão da Graça SD, Proulx C, Zhang J, Febbraio M, Soto Y, Lubell WD, Ong H, Marleau S. Frégeau G, et al. Among authors: mellal k. Atherosclerosis. 2020 Aug;307:52-62. doi: 10.1016/j.atherosclerosis.2020.06.010. Epub 2020 Jul 6. Atherosclerosis. 2020. PMID: 32721647 Free article.
Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice.
Brito V, Mellal K, Zoccal KF, Soto Y, Ménard L, Sarduy R, Faccioli LH, Ong H, Vázquez AM, Marleau S. Brito V, et al. Among authors: mellal k. Front Pharmacol. 2017 Nov 1;8:782. doi: 10.3389/fphar.2017.00782. eCollection 2017. Front Pharmacol. 2017. PMID: 29163168 Free PMC article.